Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve the unaudited financial results ....
Awaiting price reaction for this filing.
Sarda Proteins Ltd has informed BSE that its Board of Directors will meet on Saturday, 14 February 2026 to consider and approve the standalone unaudited financial results for the quarter and nine months ended 31 December 2025. The company has also confirmed that the trading window for dealing in its securities has been closed from 1 January 2026 and will remain closed until 48 hours after the results are declared. The intimation is filed under Regulation 29(1) of SEBI (LODR) Regulations, 2015. No financial figures, outlook, or other business matters are disclosed in this filing — it is purely a procedural announcement ahead of the results.
This is a routine regulatory intimation and has no direct impact on the stock price. Investors should watch for the actual Q3 FY26 results on or after 14 February 2026 for any meaningful business signals.